iShares Health Innovation Active ETF holds a quantitatively derived Bronze Morningstar Medalist Rating. The rating reflects that it has scored better than the norm on factors Morningstar research associates with future outperformance relative to category peers.
iShares Health Innovation Active ETF BMED
Morningstar’s Analysis BMED
Will BMED outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 42.9
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Danaher Corp | 5.19 | 706,160 | Healthcare |
Moderna Inc | 5.02 | 682,964 | Healthcare |
Gilead Sciences Inc | 5.00 | 679,475 | Healthcare |
AbbVie Inc | 4.85 | 659,676 | Healthcare |
Thermo Fisher Scientific Inc | 4.39 | 597,178 | Healthcare |
Johnson & Johnson | 4.13 | 561,353 | Healthcare |
BlackRock Cash Funds Treasury SL Agency | 4.12 | 560,000 | Cash and Equivalents |
Waters Corp | 3.69 | 501,388 | Healthcare |
IQVIA Holdings Inc | 3.65 | 496,346 | Healthcare |
Biogen Inc | 3.51 | 477,622 | Healthcare |